Back to Search Start Over

ACE I/D gene polymorphisms and polycystic ovary syndrome manifestations.

Authors :
Asadi M
Nickhah Klashami Z
Panahi N
Oheb Y
Khorasani S
Amoli MM
Source :
Journal of diabetes and metabolic disorders [J Diabetes Metab Disord] 2023 Oct 30; Vol. 23 (1), pp. 681-688. Date of Electronic Publication: 2023 Oct 30 (Print Publication: 2024).
Publication Year :
2023

Abstract

Objective: Polycystic ovary syndrome (PCOS) is a common multifactorial endocrine disorder affecting women of reproductive age. ACE enzyme is involved in the physiopathology of the ovarian system, and there are inconsistencies between studies regarding the association between ACE gene variants and PCOS. The objective of this study is to evaluate the association between ACE I/D gene polymorphisms and PCOS, as well as its clinical manifestations, in Iranian women with PCOS.<br />Design: This study included 140 patients with PCOS and 153 controls without the disease. Samples were collected from Yas Hospital Complex in Tehran-Iran during 2018 to 2022. Genomic DNA was obtained from whole blood samples using salt extraction, and genotyping was carried out using polymerase chain reaction (PCR).<br />Results: Variants of DD, ID, and II were observed in 31.4, 44.3, and 24.3% of PCOS, and 38.6, 44.1, and 17.2% of control group, respectively. The frequency of ACE gene variants did not differ between PCOS patients and control group. A significant difference was observed between the frequency of elevated LH to FSH ratio > 2 and ACE gene polymorphisms in patients with PCOS (OR: 0.32 (0.12-0.88), P value 0.024) with lower frequency observed in D allele carriers.<br />Conclusion: This study indicate that although ACE I/D variants frequency in PCOS women is similar to non-PCOS women, it may be involved in the pathogenesis of the disease through mechanisms regulating steroidogenesis in the ovary and suggests that ACE might be related to exacerbated clinical manifestations of PCOS which requires further investigations.<br />Competing Interests: Conflict of interestThe authors declare no conflict of interest.<br /> (© The Author(s), under exclusive licence to Tehran University of Medical Sciences 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.)

Details

Language :
English
ISSN :
2251-6581
Volume :
23
Issue :
1
Database :
MEDLINE
Journal :
Journal of diabetes and metabolic disorders
Publication Type :
Academic Journal
Accession number :
38932810
Full Text :
https://doi.org/10.1007/s40200-023-01335-w